Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir
- 1 October 1982
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 2 (5), 243-254
- https://doi.org/10.1016/0166-3542(82)90048-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapyAntimicrobial Agents and Chemotherapy, 1982
- Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with AcyclovirNew England Journal of Medicine, 1982
- Acyclovir — A review of the preclinical and early clinical data of a new antiherpes drugAntiviral Research, 1981
- Effects of Oral Treatment with Acyclovir and Bromovinyldeoxyuridine on the Establishment and Maintenance of Latent Herpes Simplex Virus Infection in MiceJournal of General Virology, 1981
- Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistanceNature, 1981
- Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.BMJ, 1980
- Strategies of drug resistance in herpes simplexNature, 1980
- Isolation and Characterization of Acyclovir-resistant Mutants of Herpes Simplex VirusJournal of General Virology, 1980
- Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1980
- Mutant strains of herpes simplex deficient in thymidine kinase-inducing activityVirology, 1964